.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
McKinsey
US Department of Justice
Dow
Novartis
Cantor Fitzgerald
Fish and Richardson
Fuji
Citi

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205415

« Back to Dashboard
NDA 205415 describes PINDOLOL, which is a drug marketed by Idt Australia Ltd, Mylan Pharms Inc, Nostrum Labs Inc, G And W Labs Inc, Purepac Pharm, Watson Labs, Sun Pharm Inds, and Nostrum Labs, and is included in thirteen NDAs. It is available from five suppliers. Additional details are available on the PINDOLOL profile page.

The generic ingredient in PINDOLOL is pindolol. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the pindolol profile page.

Summary for NDA: 205415

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 205415

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 205415

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PINDOLOL
pindolol
TABLET;ORAL 205415 ANDA Nostrum Laboratories, Inc. 29033-028 29033-028-01 100 TABLET in 1 BOTTLE (29033-028-01)
PINDOLOL
pindolol
TABLET;ORAL 205415 ANDA Nostrum Laboratories, Inc. 29033-029 29033-029-01 100 TABLET in 1 BOTTLE (29033-029-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jan 13, 2016TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jan 13, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Moodys
Covington
Daiichi Sankyo
Harvard Business School
McKinsey
Accenture
Colorcon
Dow
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot